NovaDel Gets Potential $27M in Deal for Anti-Nausea Drug

tmcnet.com     May 20, 2008            

Flemington, N.J.-based NovaDel plans to use the money to "reinitiate a lot of our clinical development" that had been curtailed due to a lack of money, Mike Spicer, chief financial officer, told BioWorld Today. Under the deal, Paris-based BioAlliance will be responsible for European regulatory... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies